Faecal alpha-1-antitrypsin in chronic inflammatory bowel disease.
نویسندگان
چکیده
منابع مشابه
Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases.
Intestinal protein loss in chronic inflammatory bowel diseases may be easily determined by measurement of alpha-1-antitrypsin (alpha 1-AT) stool concentration and alpha 1-AT clearance. Both parameters were significantly raised in 36 and 34 patients respectively with chronic inflammatory bowel diseases, compared with eight patients with non-inflammatory bowel diseases, or 19 healthy volunteers. ...
متن کاملAssessment of Alpha-1 Antitrypsin Deficiency in Patients with Severe Chronic Obstructive Pulmonary Disease
Background and Aims: Chronic obstructive pulmonary disease (COPD) is a kind of pulmonary diseases characterized by chronic obstruction of lung that is in the form of a diffuse narrowing of airways resulting in air flow resistance. Alpha-1 antitrypsin (AAT) deficiency is genetically relatively common risk factor in patients with COPD throughout the world and the exact cause of its prevalence is ...
متن کاملFaecal excretion of alpha-1-antitrypsin in acute diarrhoea.
High levels of faecal alpha-1-antitrypsin were found in children suffering from acute rotavirus diarrhoea and in children with diarrhoea in whom no microbial pathogen could be established. The results suggest that transient protein-losing enteropathy is common in acute childhood diarrhoea and may influence the outcome of the disease.
متن کاملAlpha 1-antitrypsin deficiency, complement activation, and chronic liver disease.
Activation of the complement system, the main humoral mediator of inflammation, is restrained by the action of enzyme inhibitors including alpha 1-antitrypsin. Deficiency leads to chronic liver disease in about one in five children with this genetic defect. Complement activation was investigated in 34 children with alpha 1 AT deficiency (12 with minimal, 10 with moderate, and 12 with severe liv...
متن کاملQualitative differences in faecal alpha-1-antitrypsin in patients with Crohn's disease.
Correspondence Qualitative differences in faecal alpha-1-antitrypsin in patients with Crohn's disease SIR,-The use of faecal alpha-1-antitrypsin (A-1-AT) in the assessment of Crohn's disease (CD) activity remains controversial. In a recent study Fischbach et al found no correlation of faecal A-1-AT with ESR, serum albumin, orosomucoid, activity index of Van Hees, or CDAI.' Conversely, faecal A-...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Gut
سال: 1988
ISSN: 0017-5749
DOI: 10.1136/gut.29.2.262